Dynorphin, stress, and depression
暂无分享,去创建一个
[1] P. Schwartzkroin,et al. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[2] Yan Zhang,et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. , 2003, The Journal of pharmacology and experimental therapeutics.
[3] S. Southwick,et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. , 1995, The American journal of psychiatry.
[4] Y. Shaham,et al. Role of ERK in cocaine addiction , 2006, Trends in Neurosciences.
[5] Y. Hurd,et al. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain , 1996, Neuroscience.
[6] J. L. Howard,et al. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. , 2004, European journal of pharmacology.
[7] J. Bains,et al. Retrograde Opioid Signaling Regulates Glutamatergic Transmission in the Hypothalamus , 2009, The Journal of Neuroscience.
[8] F. Holsboer,et al. Stress and the brain: from adaptation to disease , 2005, Nature Reviews Neuroscience.
[9] H. Fields,et al. Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor , 1997, Nature.
[10] Stanley J. Watson,et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.
[11] Rajita Sinha,et al. Chronic Stress, Drug Use, and Vulnerability to Addiction , 2008, Annals of the New York Academy of Sciences.
[12] C. Coscia,et al. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. , 2005, The Journal of biological chemistry.
[13] R. Bandler,et al. Parallel circuits mediating distinct emotional coping reactions to different types of stress , 2001, Neuroscience & Biobehavioral Reviews.
[14] Jingyuan Chen,et al. Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases , 2003, Brain Research.
[15] Jennifer M. Mitchell,et al. Modulation of Anxiety-Like Behavior and Morphine Dependence in CREB-Deficient Mice , 2004, Neuropsychopharmacology.
[16] F. Crews,et al. CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. , 2005, Alcoholism, clinical and experimental research.
[17] Masaaki Iwata,et al. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects , 2004, Journal of neurochemistry.
[18] T. Shippenberg,et al. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[19] B. McEwen. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. , 2008, European journal of pharmacology.
[20] H. Fields,et al. Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception. , 2005, Journal of neurophysiology.
[21] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .
[22] Elyssa B. Margolis,et al. Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. , 2005, Journal of neurophysiology.
[23] Nathan J. Marchant,et al. Coexpression of prodynorphin and corticotrophin‐releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division , 2007, The Journal of comparative neurology.
[24] S. Maier,et al. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels , 1992, Brain Research.
[25] E. Gould,et al. Adrenal steroid influences on the survival of hippocampal neurons. , 1990, Biochemical pharmacology.
[26] B. Moghaddam,et al. Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress , 1999, Journal of neurochemistry.
[27] E. Nestler,et al. Psychobiology and molecular genetics of resilience , 2009, Nature Reviews Neuroscience.
[28] J. Frey,et al. Long-Term Effects of Brief Acute Stress on Cellular Signaling and Hippocampal LTP , 2006, The Journal of Neuroscience.
[29] S. Cragg,et al. Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway , 2008, Brain Research Reviews.
[30] R. Spanagel,et al. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Shippenberg,et al. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists , 1987, Brain Research.
[32] R. Tao,et al. μ-Opioids disinhibit and κ-opioids inhibit serotonin efflux in the dorsal raphe nucleus , 2005, Brain Research.
[33] Christopher F. Shay,et al. Endogenous κ Opioid Activation Mediates Stress-Induced Deficits in Learning and Memory , 2009, The Journal of Neuroscience.
[34] G. Koob. A Role for Brain Stress Systems in Addiction , 2008, Neuron.
[35] M. Todtenkopf,et al. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. , 2004, Psychopharmacology.
[36] J. Fallon,et al. Distribution of dynorphin and enkephalin peptides in the rat brain , 1986, The Journal of comparative neurology.
[37] Julia C. Lemos,et al. The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System , 2008, The Journal of Neuroscience.
[38] R. Neve,et al. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety , 2004, Biological Psychiatry.
[39] M. Bruchas,et al. Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by κ Opioid Activation of p38 Mitogen-Activated Protein Kinase , 2007, The Journal of Neuroscience.
[40] M. Hiramatsu,et al. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy. , 2004, Brain research.
[41] J. Pintar,et al. Quantitative autoradiographic mapping of the ORL1, μ-, δ- and κ-receptors in the brains of knockout mice lacking the ORL1 receptor gene , 2001, Brain Research.
[42] G. Koob,et al. Brain stress systems in the amygdala and addiction , 2009, Brain Research.
[43] S. Kapur,et al. Direct Activation of the Ventral Striatum in Anticipation of Aversive Stimuli , 2003, Neuron.
[44] H. Emrich,et al. Psychotomimesis mediated by kappa opiate receptors , 1986, Science.
[45] E. Butelman,et al. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors , 2005, Psychopharmacology.
[46] G. Di Chiara,et al. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.
[47] M. Banasr,et al. Differential effects of chronic antidepressant treatment on shuttle box escape deficits induced by uncontrollable stress , 2008, Psychopharmacology.
[48] Gareth Leng,et al. Dendritic peptide release and peptide-dependent behaviours , 2006, Nature Reviews Neuroscience.
[49] L. Swanson,et al. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit , 1997, Brain Research.
[50] M. Takahashi,et al. Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. , 1990, Japanese journal of pharmacology.
[51] E. V. Bockstaele,et al. Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus , 2007, Neuroscience.
[52] R. Sapolsky. Why Stress Is Bad for Your Brain , 1996, Science.
[53] C. Nemeroff,et al. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression , 2006, Current psychiatry reports.
[54] Declan Jones,et al. Long term κ-opioid receptor blockade following nor-binaltorphimine , 1992 .
[55] T. Shippenberg,et al. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. , 1987, Brain research.
[56] J. Blendy,et al. Making a bad thing worse: adverse effects of stress on drug addiction. , 2008, The Journal of clinical investigation.
[57] R. Duman,et al. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.
[58] M. Barrot,et al. Regional and Cellular Mapping of cAMP Response Element-Mediated Transcription during Naltrexone-Precipitated Morphine Withdrawal , 2002, The Journal of Neuroscience.
[59] M. Brandão,et al. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. , 2000, Behavioural pharmacology.
[60] V. Neugebauer,et al. The Amygdala and Persistent Pain , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[61] S. Watson,et al. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. , 2007, European journal of pharmacology.
[62] J. Buckingham,et al. Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat. , 1986, Neuroendocrinology.
[63] E. Nestler,et al. The many faces of CREB , 2005, Trends in Neurosciences.
[64] Michael Rickels,et al. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.
[65] Michael Davis,et al. Central Oxytocin, Vasopressin, and Corticotropin-Releasing Factor Receptor Densities in the Basal Forebrain Predict Isolation Potentiated Startle in Rats , 2005, The Journal of Neuroscience.
[66] Elyssa B. Margolis,et al. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[67] James L. Howard,et al. Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist , 2004 .
[68] C. Chavkin,et al. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.
[69] Christian Broberger,et al. Neuropeptides — an overview , 2000, Neuropharmacology.
[70] E. Richelson. Pharmacology of antidepressants. , 2001, Psychopathology.
[71] Deanna L. Wallace,et al. Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] M. Shenton,et al. Clarifying the Origin of Biological Abnormalities in PTSD Through the Study of Identical Twins Discordant for Combat Exposure , 2006, Annals of the New York Academy of Sciences.
[73] Anantha Shekhar,et al. Serotonergic Systems, Anxiety, and Affective Disorder , 2008, Annals of the New York Academy of Sciences.
[74] A. Herz,et al. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro) , 1986, Brain Research.
[75] B. Richmond,et al. Role of perirhinal cortex in object perception, memory, and associations , 2001, Current Opinion in Neurobiology.
[76] G. Stuber,et al. Corticotropin‐releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C‐dependent enhancement of Ih , 2008, The Journal of physiology.
[77] G. Valdez,et al. κ Agonist-Induced Reinstatement of Cocaine Seeking in Squirrel Monkeys: A Role for Opioid and Stress-Related Mechanisms , 2007, Journal of Pharmacology and Experimental Therapeutics.
[78] M. Le Moal,et al. Novelty-seeking in rats--biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. , 1996, Neuropsychobiology.
[79] J. Zentner,et al. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex , 2006, British journal of pharmacology.
[80] B. McEwen,et al. Effects of adrenal steroid manipulations and repeated restraint stress on dynorphin mRNA levels and excitatory amino acid receptor binding in hippocampus , 1995, Brain Research.
[81] M. al’Absi,et al. Stress and Addiction: Biological and Psychological Mechanisms. , 2007 .
[82] C. Schwarzer,et al. Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain , 2006, Neuropeptides.
[83] J. Blendy,et al. μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward , 2005, Neuron.
[84] S. Morrison,et al. Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in OFF and NEUTRAL cells in the rostral ventromedial medulla. , 2006, Journal of neurophysiology.
[85] H. Akil,et al. Neurobiological Correlates of Individual Differences in Novelty-Seeking Behavior in the Rat: Differential Expression of Stress-Related Molecules , 2000, The Journal of Neuroscience.
[86] C. Schwarzer. 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. , 2009, Pharmacology & therapeutics.
[87] Rachael L Neve,et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[88] C. Salvadore,et al. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions , 2004, BMC Neuroscience.
[89] M. Hiramatsu,et al. Involvement of κ-opioid receptors and σ receptors in memory function demonstrated using an antisense strategy , 2004, Brain Research.
[90] Oye Gureje,et al. Comorbidity of pain and anxiety disorders , 2008, Current psychiatry reports.
[91] R. Nicoll,et al. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation , 1993, Nature.
[92] E. Nestler,et al. The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.
[93] E. V. Van Bockstaele,et al. Dynorphin and stress‐related peptides in rat locus coeruleus: Contribution of amygdalar efferents , 2008, The Journal of comparative neurology.
[94] M. Meaney,et al. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. , 2001, Annual review of neuroscience.
[95] Z. Wang,et al. Pronociceptive Actions of Dynorphin Maintain Chronic Neuropathic Pain , 2001, The Journal of Neuroscience.
[96] D. Johnston,et al. Protein Kinase Modulation of Dendritic K+ Channels in Hippocampus Involves a Mitogen-Activated Protein Kinase Pathway , 2002, The Journal of Neuroscience.
[97] T. Kaneko,et al. Prodynorphin storage and processing in axon terminals and dendrites , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] P. Kalivas,et al. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity , 1991, Brain Research Reviews.
[99] J. Hensler,et al. Serotonergic modulation of the limbic system , 2006, Neuroscience & Biobehavioral Reviews.
[100] K. Roth,et al. Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. , 1983, Science.
[101] R. Huganir,et al. MAPK cascade signalling and synaptic plasticity , 2004, Nature Reviews Neuroscience.
[102] L. Bohn,et al. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. , 2001, Journal of neurochemistry.
[103] W. Carlezon,et al. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation , 2007, Nature Protocols.
[104] J. Pintar,et al. Prior Activation of Kappa Opioid Receptors by U50,488 Mimics Repeated Forced Swim Stress to Potentiate Cocaine Place Preference Conditioning , 2006, Neuropsychopharmacology.
[105] R. Wise,et al. Brain dopamine and reward. , 1989, Annual review of psychology.
[106] R. Pinnock. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro. , 1992, Neuroscience.
[107] C. Bourque,et al. Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus , 2004, The Journal of physiology.
[108] D. Price,et al. Opioid precursor gene expression in the human hypothalamus , 1995, The Journal of comparative neurology.
[109] E. Bennett,et al. Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick , 2005, Psychopharmacology.
[110] E. V. Van Bockstaele,et al. Convergent regulation of locus coeruleus activity as an adaptive response to stress. , 2008, European journal of pharmacology.
[111] C. Chavkin,et al. Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[112] M. Bruchas,et al. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. , 2007, The Journal of biological chemistry.
[113] M. Wadenberg. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. , 2006, CNS drug reviews.
[114] A. Herz,et al. Central kappa- and mu-opiate receptors mediate ACTH-release in rats. , 1985, Endocrinology.
[115] James L. Howard,et al. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats , 2005, Psychopharmacology.
[116] A. Basbaum,et al. Ultrastructural analysis of dynorphin B–immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat , 1989, The Journal of comparative neurology.
[117] J. V. Aldrich,et al. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. , 2007, European journal of pharmacology.
[118] R. Neve,et al. Brain Reward Regulated by AMPA Receptor Subunits in Nucleus Accumbens Shell , 2006, The Journal of Neuroscience.
[119] C. Chavkin,et al. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus , 1993, Nature.
[120] R. Tao,et al. Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System , 2002, Journal of Pharmacology and Experimental Therapeutics.
[121] C. Gaveriaux-Ruff,et al. Inflammatory pain is enhanced in delta opioid receptor‐knockout mice , 2008, The European journal of neuroscience.
[122] G. Alheid. Extended Amygdala and Basal Forebrain , 2003, Annals of the New York Academy of Sciences.
[123] E. Ur,et al. The effects of spiradoline (U‐62066E), a κ‐opioid receptor agonist, on neuroendocrine function in man , 1997, British journal of pharmacology.
[124] Elyssa B. Margolis,et al. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[125] E. V. Van Bockstaele,et al. Subcellular targeting of kappa‐opioid receptors in the rat nucleus locus coeruleus , 2009, The Journal of comparative neurology.
[126] Y. Yanagawa,et al. A Specialized Subclass of Interneurons Mediates Dopaminergic Facilitation of Amygdala Function , 2005, Neuron.
[127] H. Yamamura,et al. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. , 1992, The Journal of pharmacology and experimental therapeutics.
[128] P. Renshaw,et al. Antidepressant-like effects of cytidine in the forced swim test in rats , 2002, Biological Psychiatry.
[129] T. Vanderah,et al. Neuropathic pain: the paradox of dynorphin. , 2001, Molecular interventions.
[130] J. Zhu,et al. State-dependent Ras signaling and AMPA receptor trafficking. , 2005, Genes & development.
[131] R. Kessler,et al. The effects of stressful life events on depression. , 1997, Annual review of psychology.
[132] S. Maier,et al. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor , 2005, Neuroscience & Biobehavioral Reviews.
[133] R. Wise,et al. Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward , 1996, Psychopharmacology.
[134] Elyssa B. Margolis,et al. κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons , 2003, The Journal of Neuroscience.
[135] R. D. Plnnock. A highly selective κ-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro , 1992, Neuroscience.
[136] Cécile Béguin,et al. Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.
[137] R. Porsolt,et al. Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.
[138] Mark J. Thomas,et al. Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis , 2009, Neuropharmacology.
[139] M. Marinelli,et al. Interaction between glucocorticoid hormones, stress and psychostimulant drugs * , 2002, The European journal of neuroscience.
[140] S. Turgeon,et al. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization , 1997, Brain Research.
[141] L. Bohn,et al. Kappa opioids promote the proliferation of astrocytes via Gβγ and β‐arrestin 2‐dependent MAPK‐mediated pathways , 2008, Journal of neurochemistry.
[142] C. Pittenger,et al. Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.
[143] J. Bossert,et al. Cocaine‐induced CREB phosphorylation in nucleus accumbens of cocaine‐sensitized rats is enabled by enhanced activation of extracellular signal‐related kinase, but not protein kinase A , 2005, Journal of neurochemistry.
[144] R. Wightman,et al. Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli , 2008, Nature Neuroscience.
[145] D. Surmeier,et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons , 2007, Trends in Neurosciences.
[146] Joseph E LeDoux,et al. The influence of stress hormones on fear circuitry. , 2009, Annual review of neuroscience.
[147] M. Dubé,et al. Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.
[148] Eric J. Nestler,et al. Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect , 2002, The Journal of Neuroscience.
[149] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[150] A. Bilkei-Gorzo,et al. Control of hormonal stress reactivity by the endogenous opioid system , 2008, Psychoneuroendocrinology.
[151] V. Pickel,et al. Cellular Sites for Dynorphin Activation of κ-Opioid Receptors in the Rat Nucleus Accumbens Shell , 1999, The Journal of Neuroscience.
[152] B. Roques,et al. Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal , 1998, The EMBO journal.
[153] Y. Nagumo,et al. Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala , 2006, Neuropsychopharmacology.
[154] C. Schwarzer,et al. Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone , 2009, Neuropsychopharmacology.
[155] S. Izenwasser,et al. Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity. , 2008, European journal of pharmacology.
[156] A. Hidalgo,et al. Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. , 1993, Brain research.
[157] G. Koob. Neurobiological substrates for the dark side of compulsivity in addiction , 2009, Neuropharmacology.
[158] M. Todtenkopf,et al. Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats , 2004, Psychopharmacology.
[159] M. Sheng,et al. Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Ras-ERK Signaling and AMPA Receptor Trafficking , 2005, Neuron.
[160] M. Bruchas,et al. Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria , 2007, The Journal of Neuroscience.
[161] E. Meloni,et al. Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.
[162] A. Zangen,et al. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression , 2001, Brain Research.
[163] E. V. Bockstaele,et al. Presynaptic Inhibition of Diverse Afferents to the Locus Ceruleus by κ-Opiate Receptors: A Novel Mechanism for Regulating the Central Norepinephrine System , 2008, The Journal of Neuroscience.
[164] Philip S. Portoghese,et al. Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[165] M. Misawa,et al. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. , 1992, Japanese journal of pharmacology.
[166] C. Coscia,et al. μ and κ Opioid Receptors Activate ERK/MAPK via Different Protein Kinase C Isoforms and Secondary Messengers in Astrocytes* , 2005, Journal of Biological Chemistry.
[167] M. Laorden,et al. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. , 2000, Life sciences.
[168] M. L. Macdonald,et al. Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue , 2009, Molecular Pharmacology.
[169] M. Millan. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. , 2004, European journal of pharmacology.
[170] E. Abercrombie,et al. Differential Effect of Stress on In Vivo Dopamine Release in Striatum, Nucleus Accumbens, and Medial Frontal Cortex , 1989, Journal of neurochemistry.
[171] M. Caron,et al. Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance* , 2004, Journal of Biological Chemistry.
[172] A. Kelley,et al. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde and retrograde-horseradish peroxidase study , 1982, Neuroscience.
[173] C. Drake,et al. Opioid systems in the dentate gyrus. , 2007, Progress in brain research.
[174] J. Pintar,et al. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. , 2001, Brain research.
[175] G. Stalla,et al. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats , 1987, Brain Research.
[176] D. Peckys,et al. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study , 1999, Neuroscience.
[177] B. McEwen. Stress and hippocampal plasticity. , 1999, Annual review of neuroscience.
[178] W. Carlezon,et al. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behavior , 2009, PAIN®.
[179] A. Herz,et al. Feedback inhibition of opioid peptide release in the hypothalamus of the rat , 1987, Neuroscience.
[180] David A. Morilak,et al. Role of brain norepinephrine in the behavioral response to stress , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[181] E. Meloni,et al. Behavioral and Anatomical Interactions between Dopamine and Corticotropin-Releasing Factor in the Rat , 2006, The Journal of Neuroscience.
[182] M. Bruchas,et al. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2 , 2008, Neuroreport.
[183] F. Porreca,et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats , 2000, Pain.
[184] A. Basbaum,et al. Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain , 2009, Cell.
[185] M. Connor,et al. How opioids inhibit GABA-mediated neurotransmission , 1997, Nature.
[186] Angel Y. F. Kam,et al. κ-Opioid Receptor Signals through Src and Focal Adhesion Kinase to Stimulate c-Jun N-Terminal Kinases in Transfected COS-7 Cells and Human Monocytic THP-1 Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.
[187] C. Chavkin,et al. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. , 1996, Molecular pharmacology.
[188] C. Chavkin. Dynorphins are endogenous opioid peptides released from granule cells to act neurohumorly and inhibit excitatory neurotransmission in the hippocampus. , 2000, Progress in brain research.
[189] R. Lefkowitz,et al. β-Arrestins and Cell Signaling , 2007 .
[190] N. Hiroi,et al. Regulation of cocaine reward by CREB. , 1998, Science.
[191] H. Fields,et al. Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms. , 2003, Journal of neurophysiology.
[192] Hussain Jafri,et al. An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.
[193] B. McEwen,et al. Stress induces activation of stress‐activated kinases in the mouse brain , 2004, Journal of neurochemistry.
[194] V. Chefer,et al. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum , 2008, Psychopharmacology.
[195] E. Stuenkel,et al. κ-Opioid Receptor Activation Modulates Ca2+Currents and Secretion in Isolated Neuroendocrine Nerve Terminals , 1997, The Journal of Neuroscience.
[196] J. Zubieta,et al. Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[197] J. Riba,et al. Pattern of use and subjective effects of Salvia divinorum among recreational users. , 2006, Drug and alcohol dependence.
[198] W. Katon,et al. Depression and pain comorbidity: a literature review. , 2003, Archives of internal medicine.
[199] R. Elde,et al. The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus , 2000, Neuroscience.
[200] R. Tao,et al. mu-Opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus. , 2005, Brain research.
[201] K. Miczek,et al. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study , 1996, Brain Research.
[202] S. Hyman,et al. Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum , 1995, Neuron.
[203] G. Chiara,et al. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression , 1999, Biological Psychiatry.
[204] M. Häusser,et al. Neuronal Microcircuits: Frequency-Dependent Flow of Inhibition , 2004, Current Biology.
[205] Cécile Béguin,et al. Kappa-opioid ligands in the study and treatment of mood disorders. , 2009, Pharmacology & therapeutics.
[206] C. Chavkin,et al. κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses , 2003, The Journal of Neuroscience.
[207] R. Dworkin,et al. Congenital insensitivity to pain: an update , 2003, Pain.
[208] Yvette I. Sheline,et al. Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.
[209] V. Pickel,et al. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[210] Shuang Li,et al. Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System , 2006, Neuropsychopharmacology.
[211] Michael Davis,et al. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer , 2008, Brain Structure and Function.
[212] M. Le Moal,et al. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[213] T. Shippenberg,et al. Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation , 2008, PAIN.
[214] B. Cohen,et al. The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward , 2008, Biological Psychiatry.
[215] R. Przewłocki,et al. The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord , 1987, Brain Research.
[216] H. Fields,et al. Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla , 1998, Neuroreport.
[217] T. Endoh,et al. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. , 1992, Archives internationales de pharmacodynamie et de therapie.
[218] M. Bruchas,et al. Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* , 2006, Journal of Biological Chemistry.
[219] D. Jones,et al. Long term kappa-opioid receptor blockade following nor-binaltorphimine. , 1992, European journal of pharmacology.
[220] J. V. Aldrich,et al. Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development , 2009, The AAPS Journal.
[221] M. Marinelli. Dopaminergic Reward Pathways and Effects of Stress , 2007 .
[222] D. Charney,et al. Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.
[223] V. Chefer,et al. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. , 2008, CNS & neurological disorders drug targets.
[224] R. Lefkowitz,et al. Beta-arrestins and cell signaling. , 2007, Annual review of physiology.
[225] G. Aston-Jones,et al. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence , 2008, Brain Structure and Function.
[226] C. Chavkin,et al. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system , 2008, Psychopharmacology.
[227] J. Gutkind. Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors , 2000, Science's STKE.
[228] C. Gaveriaux-Ruff,et al. Exploring the opioid system by gene knockout , 2002, Progress in Neurobiology.
[229] J. Blendy,et al. Behavioral / Systems / Cognitive cAMP Response Element-Binding Protein Is Required for Stress But Not Cocaine-Induced Reinstatement , 2004 .
[230] D. Hedges,et al. Hippocampal and amygdala volumes in children and adults with childhood maltreatment‐related posttraumatic stress disorder: A meta‐analysis , 2008, Hippocampus.
[231] M. Bruchas,et al. Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase* , 2007, Journal of Biological Chemistry.
[232] C. Nemeroff,et al. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders , 1999, Biological Psychiatry.
[233] A. Hidalgo,et al. Involvement of spinal κ opioid receptors in a type of footshock induced analgesia in mice , 1993, Brain Research.
[234] L. Terenius,et al. Big Dynorphin, a Prodynorphin-Derived Peptide Produces NMDA Receptor-Mediated Effects on Memory, Anxiolytic-Like and Locomotor Behavior in Mice , 2006, Neuropsychopharmacology.
[235] R. Neve,et al. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect , 2001, Biological Psychiatry.
[236] M. Zuckerman,et al. The psychophysiology of sensation seeking. , 1990, Journal of personality.
[237] M. Caron,et al. Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance , 2004, The Journal of Neuroscience.
[238] David P. Wolfer,et al. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice , 2007, Neurobiology of Learning and Memory.
[239] E. Nestler,et al. Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens , 2001, The Journal of Neuroscience.
[240] A. Dierich,et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. , 2000, Nature genetics.
[241] H. Fields,et al. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. , 1997, Nature.
[242] Y. Sheline. Neuroimaging studies of mood disorder effects on the brain , 2003, Biological Psychiatry.